The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Telomeres and Telomerase in Cardiovascular Diseases
Open accessAbstract
Telomeres are tandem repeat DNA sequences present at the ends of each eukaryotic chromosome to stabilize the genome structure integrity. Telomere lengths progressively shorten with each cell division. Inflammation and oxidative stress, which are implicated as major mechanisms underlying cardiovascular diseases, increase the rate of telomere shortening and lead to cellular senescence. In clinical studies, cardiovascular risk factors such as smoking, obesity, sedentary lifestyle, and hypertension have been associated with short leukocyte telomere length. In addition, low telomerase activity and short leukocyte telomere length have been observed in atherosclerotic plaque and associated with plaque instability, thus stroke or acute myocardial infarction. The aging myocardium with telomere shortening and accumulation of senescent cells limits the tissue regenerative capacity, contributing to systolic or diastolic heart failure. In addition, patients with ion-channel defects might have genetic imbalance caused by oxidative stress-related accelerated telomere shortening, which may subsequently cause sudden cardiac death. Telomere length can serve as a marker for the biological status of previous cell divisions and DNA damage with inflammation and oxidative stress. It can be integrated into current risk prediction and stratification models for cardiovascular diseases and can be used in precise personalized treatments. In this review, we summarize the current understanding of telomeres and telomerase in the aging process and their association with cardiovascular diseases. In addition, we discuss therapeutic interventions targeting the telomere system in cardiovascular disease treatments.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inflamm‐aging: An Evolutionary Perspective on Immunosenescence
FRANCESCHI, C., BONAFÈ, M., VALENSIN, S., OLIVIERI, F., DE LUCA, M., OTTAVIANI, E., & DE BENEDICTIS, G. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06651.x · Cited by 5,358 · cited 1×
“Immunosenescence is generally used to described the age-associated functional decline of immune system [39], which is associated with increased susceptibility to infectious diseases, reduced immunity from vaccination, increased autoimmunity, and tissue damage from dysregulated inflammation.”
BackgroundShelterin: the protein complex that shapes and safeguards human telomeres
de Lange, T. (2005) · Genes & Development · doi:10.1101/gad.1346005 · Cited by 3,056 · cited 1×
“Moreover, telomeres are coated with a complex of six capping proteins (telomere repeat-binding factor 1 (TRF1), telomere repeat-binding factor 2 (TRF2), repressor activator protein 1 (Rap1), TRF1 and TRF2 interacting nuclear protein 2 (TIN2), Tripeptidyl-peptidase 1 (TPP1), and protection of telomere 1 (POT1)), also k…”
Oxidative stress shortens telomeres
von Zglinicki, T. (2002) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(02)02110-2 · Cited by 2,524 · cited 1×
“Previous evidence indicated that increased oxidative stress and chronic inflammation are associated with a higher telomere loss and accelerated telomere shortening [65].”
BackgroundBlackburn, E. H., Epel, E. S., & Lin, J. (2015) · Science · doi:10.1126/science.aab3389 · Cited by 1,596 · cited 1×
“For example, a mean TL decrease of 117 base pairs per TERC telomere-shortening allele accounts for approximately 10% drop in functional telomere reserves in a typical middle-aged adult, and thus increases susceptibility to telomere dysfunction and replicative senescence [93].”
BackgroundObesity, cigarette smoking, and telomere length in women
Valdes, A., Andrew, T., Gardner, J., Kimura, M., Oelsner, E., Cherkas, L., Aviv, A., & Spector, T. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66630-5 · Cited by 1,363 · cited 1×
“Several common risk factors for CVD [66] such as smoking [67], diabetes mellitus [68], hypercholesterolemia [69], hypertension [70], obesity [71], physical inactivity [72], alcohol consumption [73] and psychosocial problems [74] have been associated with short TL.”
BackgroundHemann, M. T., Strong, M. A., Hao, L.-Y., & Greider, C. W. (2001) · Cell · doi:10.1016/s0092-8674(01)00504-9 · Cited by 1,219
Endothelial Cell Senescence in Human Atherosclerosis: Role of Telomere in Endothelial Dysfunction
Minamino, T., Miyauchi, H., Yoshida, T., Ishida, Y., Yoshida, H., & Komuro, I. (2002) · Circulation · doi:10.1161/01.cir.0000013836.85741.17 · Cited by 1,061
Telomerase reactivation reverses tissue degeneration in aged telomerase-deficient mice
Jaskelioff, M., Muller, F. L., Paik, J.-H., Thomas, E., Jiang, S., Adams, A. C., Sahin, E., Kost-Alimova, M., Protopopov, A., Cadiñanos, J., et al. (2011) · Nature · doi:10.1038/nature09603 · Cited by 857 · cited 1×
“Experimental studies have reported that the manipulation of telomerase activity and TL enhances or reverses senescence and aging-associated phenotypes [24,116,117].”
BackgroundLeucocyte telomere length and risk of cardiovascular disease: systematic review and meta-analysis
Haycock, P. C., Heydon, E. E., Kaptoge, S., Butterworth, A. S., Thompson, A., & Willeit, P. (2014) · BMJ · doi:10.1136/bmj.g4227 · Cited by 856 · cited 2×
“According analysis in previous studies, patients with MI have TL that is equivalent to that in controls older than 8–12 years [4,91,94].”
BackgroundMethodChronic inflammation induces telomere dysfunction and accelerates ageing in mice
Jurk, D., Wilson, C., Passos, J. F., Oakley, F., Correia-Melo, C., Greaves, L., Saretzki, G., Fox, C., Lawless, C., Anderson, R., et al. (2014) · Nature Communications · doi:10.1038/ncomms5172 · Cited by 819
Senescence Induced by Altered Telomere State, Not Telomere Loss
Karlseder, J., Smogorzewska, A., & de Lange, T. (2002) · Science · doi:10.1126/science.1069523 · Cited by 796
Leukocyte Telomere Length and Cardiovascular Disease in the Cardiovascular Health Study
Fitzpatrick, A. L., Kronmal, R. A., Gardner, J. P., Psaty, B. M., Jenny, N. S., Tracy, R. P., Walston, J., Kimura, M., & Aviv, A. (2006) · American Journal of Epidemiology · doi:10.1093/aje/kwj346 · Cited by 773 · cited 1×
“For instance, the Cardiovascular Health Study reported that each shortened kilobase pair of TL corresponded to a threefold increased risk of MI and stroke [3].”
BackgroundTelomere length, stem cells and aging
Blasco, M. A. (2007) · Nature Chemical Biology · doi:10.1038/nchembio.2007.38 · Cited by 747 · cited 1×
“When a telomere is shortened to a critical length, the cell enters cellular senescence, which initiates a series of changes in the gene expression of replicative cell-cycle inhibitors and inhibits proliferation and then finally into apoptosis [15] as known as replicative senescence.”
BackgroundMatthews, C., Gorenne, I., Scott, S., Figg, N., Kirkpatrick, P., Ritchie, A., Goddard, M., & Bennett, M. (2006) · Circulation Research · doi:10.1161/01.res.0000233315.38086.bc · Cited by 615
Telomere shortening in atherosclerosis
Samani, N. J., Boultby, R., Butler, R., Thompson, J. R., & Goodall, A. H. (2001) · The Lancet · doi:10.1016/s0140-6736(01)05633-1 · Cited by 609
White Cell Telomere Length and Risk of Premature Myocardial Infarction
Brouilette, S., Singh, R. K., Thompson, J. R., Goodall, A. H., & Samani, N. J. (2003) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000067426.96344.32 · Cited by 590
Bernardes de Jesus, B., Vera, E., Schneeberger, K., Tejera, A. M., Ayuso, E., Bosch, F., & Blasco, M. A. (2012) · EMBO Molecular Medicine · doi:10.1002/emmm.201200245 · Cited by 548
Increased telomerase activity and comprehensive lifestyle changes: a pilot study
Ornish, D., Lin, J., Daubenmier, J., Weidner, G., Epel, E., Kemp, C., Magbanua, M. J. M., Marlin, R., Yglecias, L., Carroll, P. R., et al. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70234-1 · Cited by 430 · cited 2×
“However, some dietary and lifestyle factors such as marine omega-3 fatty acid [82], antioxidants [23], vitamin intake [83], physical activity [72], and healthy lifestyle [84] were reported to decrease rates of LTL shortening.”
BackgroundWolkowitz, O. M., Mellon, S. H., Epel, E. S., Lin, J., Dhabhar, F. S., Su, Y., Reus, V. I., Rosser, R., Burke, H. M., Kupferman, E., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017837 · Cited by 421 · cited 1×
“Most studies have reported that telomere shortening is associated with these risk factors through increased tissue inflammation and oxidative stress [75–77].”
BackgroundChimenti, C., Kajstura, J., Torella, D., Urbanek, K., Heleniak, H., Colussi, C., Di Meglio, F., Nadal-Ginard, B., Frustaci, A., Leri, A., et al. (2003) · Circulation Research · doi:10.1161/01.res.0000093985.76901.af · Cited by 386
Physical Exercise Prevents Cellular Senescence in Circulating Leukocytes and in the Vessel Wall
Werner, C., Fürster, T., Widmann, T., Pöss, J., Roggia, C., Hanhoun, M., Scharhag, J., Büchner, N., Meyer, T., Kindermann, W., et al. (2009) · Circulation · doi:10.1161/circulationaha.109.861005 · Cited by 380 · cited 1×
“In an experimental study, voluntary wheel running in mice for three weeks upregulated the activity of telomerase, increased the expression of TRF2, and reduced the expression of vascular apoptosis regulators [85].”
BackgroundCellular senescence: putting the paradoxes in perspective
Campisi, J. (2011) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2010.10.005 · Cited by 368
D’Mello, M. J. J., Ross, S. A., Briel, M., Anand, S. S., Gerstein, H., & Paré, G. (2015) · Circulation: Cardiovascular Genetics · doi:10.1161/circgenetics.113.000485 · Cited by 350 · cited 1×
“A recent systematic review and meta-analysis reported a constant positive association of decreased leukocyte TL (LTL) with cardiometabolic outcomes, where one standard deviation (SD) decrease in LTL was significantly associated with a 21%, 24%, and 37% increased risk of stroke, MI, and type 2 diabetes mellitus, respec…”
BackgroundBekaert, S., De Meyer, T., Rietzschel, E. R., De Buyzere, M. L., De Bacquer, D., Langlois, M., Segers, P., Cooman, L., Van Damme, P., Cassiman, P., et al. (2007) · Aging Cell · doi:10.1111/j.1474-9726.2007.00321.x · Cited by 348 · cited 1×
“Several common risk factors for CVD [66] such as smoking [67], diabetes mellitus [68], hypercholesterolemia [69], hypertension [70], obesity [71], physical inactivity [72], alcohol consumption [73] and psychosocial problems [74] have been associated with short TL.”
BackgroundAviv, A., Hunt, S. C., Lin, J., Cao, X., Kimura, M., & Blackburn, E. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr634 · Cited by 343
The role of CD8+ T‐cell replicative senescence in human aging
Effros, R. B., Dagarag, M., Spaulding, C., & Man, J. (2005) · Immunological Reviews · doi:10.1111/j.0105-2896.2005.00259.x · Cited by 336
Leri, A., Franco, S., Zacheo, A., Barlucchi, L., Chimenti, S., Limana, F., Nadal‐Ginard, B., Kajstura, J., Anversa, P., & Blasco, M. A. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg013 · Cited by 313
Short Telomeres Are Associated With Increased Carotid Atherosclerosis in Hypertensive Subjects
Benetos, A., Gardner, J. P., Zureik, M., Labat, C., Xiaobin, L., Adamopoulos, C., Temmar, M., Bean, K. E., Thomas, F., & Aviv, A. (2004) · Hypertension · doi:10.1161/01.hyp.0000113081.42868.f4 · Cited by 313 · cited 1×
“The association of stroke and peripheral artery disease (PAD) [6,21,90–92,106–112] with telomeres has been reported in numerous epidemiological studies.”
BackgroundDoes a Sentinel or a Subset of Short Telomeres Determine Replicative Senescence?
Zou, Y., Sfeir, A., Gryaznov, S. M., Shay, J. W., & Wright, W. E. (2004) · Molecular Biology of the Cell · doi:10.1091/mbc.e04-03-0207 · Cited by 293
Oh, H., Taffet, G. E., Youker, K. A., Entman, M. L., Overbeek, P. A., Michael, L. H., & Schneider, M. D. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.191169098 · Cited by 289
Samper, E., Flores, J. M., & Blasco, M. A. (2001) · The EMBO Reports · doi:10.1093/embo-reports/kve174 · Cited by 263 · cited 1×
“However, constitutive expression of telomerase in K5-mTERT transgenic mice revealed an anti-aging effect, accompanying with increased incidence of cancer [120,121].”
BackgroundCellular senescence in vivo: Its relevance in ageing and cardiovascular disease
Erusalimsky, J. D., & Kurz, D. J. (2005) · Experimental Gerontology · doi:10.1016/j.exger.2005.04.010 · Cited by 252 · cited 1×
“They secrete IL-6 and IL-8, intercellular adhesion molecule 1 (ICAM-1), metalloproteases, monocyte attractants, plasminogen activator inhibitor 1, and vascular endothelial growth factor [16,17].”
BackgroundWerner, C., Hanhoun, M., Widmann, T., Kazakov, A., Semenov, A., Pöss, J., Bauersachs, J., Thum, T., Pfreundschuh, M., Müller, P., et al. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.04.034 · Cited by 239 · cited 2×
“However, these exercise-induced changes were absent in both TERT−/− and endothelial nitric oxide synthase (eNOS)−/− mice, indicating the beneficial effects are medicated by TERT and eNOS [29].”
BackgroundCytomegalovirus infection is associated with increased mortality in the older population
Savva, G. M., Pachnio, A., Kaul, B., Morgan, K., Huppert, F. A., Brayne, C., & Moss, P. A. H. (2013) · Aging Cell · doi:10.1111/acel.12059 · Cited by 216
Vascular smooth muscle cell senescence in atherosclerosis
GORENNE, I., KAVURMA, M., SCOTT, S., & BENNETT, M. (2006) · Cardiovascular Research · doi:10.1016/j.cardiores.2006.06.004 · Cited by 196 · cited 1×
“The senescent VSMCs in atherosclerotic plaque also exhibit limited capacity of proliferation with increased activity of matrix-degrading enzymes as well as promote the thinning of fibrous caps and plaque rupture, which may lead to subsequent thrombosis, MI, or stroke [30].”
BackgroundBär, C., de Jesus, B. B., Serrano, R., Tejera, A., Ayuso, E., Jimenez, V., Formentini, I., Bobadilla, M., Mizrahi, J., de Martino, A., et al. (2014) · Nature Communications · doi:10.1038/ncomms6863 · Cited by 162 · cited 1×
“The treatment of adeno-associated viruses with the cardiac-specific telomerase expression resulted in elongated telomeres, attenuated cardiac dilation, improved ventricular function, and smaller infarct scars as well as improved the survival by 17% compared with that of controls [118].”
BackgroundAntagonistic effects of telomerase on cancer and aging in K5-mTert transgenic mice
González-Suárez, E., Geserick, C., Flores, J. M., & Blasco, M. A. (2005) · Oncogene · doi:10.1038/sj.onc.1208413 · Cited by 109 · cited 1×
“However, constitutive expression of telomerase in K5-mTERT transgenic mice revealed an anti-aging effect, accompanying with increased incidence of cancer [120,121].”
BackgroundBrouilette, S. W., Whittaker, A., Stevens, S. E., van der Harst, P., Goodall, A. H., & Samani, N. J. (2008) · Heart · doi:10.1136/hrt.2007.139675 · Cited by 96 · cited 1×
“Several studies in diverse populations have reported an association of shorter telomeres in circulating leukocytes with CAD [3–5,87–92].”
BackgroundPioglitazone activates aortic telomerase and prevents stress-induced endothelial apoptosis
Werner, C., Gensch, C., Pöss, J., Haendeler, J., Böhm, M., & Laufs, U. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.02.011 · Cited by 71 · cited 1×
“Additionally, pioglitazone, a peroxisome proliferator-activated receptor agonist, can increase the activity of telomerase and expression of TRF-2 as well as reduce the expression of the senescence markers p16, cell-cycle checkpoint kinase 2, and p53 [129].”
Background
Cited by
Vaiserman, A., & Krasnienkov, D. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2020.630186 · Cited by 454
Stress and telomere shortening: Insights from cellular mechanisms
Lin, J., & Epel, E. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101507 · Cited by 376
Telomeres as Therapeutic Targets in Heart Disease
Yeh, J.-K., Lin, M.-H., & Wang, C.-Y. (2019) · JACC: Basic to Translational Science · doi:10.1016/j.jacbts.2019.05.009 · Cited by 49
Self-citationHowell, M. P., Jones, C. W., Herman, C. A., Mayne, C. V., Fernandez, C., Theall, K. P., Esteves, K. C., & Drury, S. S. (2022) · BMC Medicine · doi:10.1186/s12916-022-02340-1 · Cited by 22
“Accelerated TL shortening, in both adults and pediatric populations, has been related to many aging related diseases including cardiovascular disease [28], obesity [29], and diabetes [30].”
BackgroundCorrelation of telomere length between full and preterm neonates and their mothers
Vakonaki, E., Vitiadou, M., Paraskevopoulou, N., Tzatzarakis, M., Baliou, S., Ioannou, P., Alegakis, A., Lamprakis, T., Fragkiadaki, P., Mylonaki, E., et al. (2025) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2025.12937 · Cited by 3
Metadata
- Authors
- Yeh, J.-K., & Wang, C.-Y.
- Venue
- Genes
- Publisher
- MDPI AG
- Published
- 2016-09-01
- Volume
- 7
- Issue
- 9
- Pages
- 58
- ISSN
- 2073-4425 (ISSN-L)
- OpenAlex
- W2514354384
- Cited by
- 200
- References
- 39
- FWCI
- 13.23
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.